A phase 2 trial of rilzabrutinib in IgG4-related disease
John H. Stone, Mollie Carruthers, Matthew C Baker, Alireza Meysami et autres
0 citationsAnnals of the Rheumatic Diseases
V. Mikol
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
47Publications signalées
1010Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Enzyme Structure and FunctionSignaling Pathways in DiseaseMonoclonal and Polyclonal Antibodies ResearchCarbohydrate Chemistry and SynthesisChronic Lymphocytic Leukemia Research
Publications récentes
LB1138 Rilzabrutinib attenuates inflammatory biomarkers in moderate-to-severe atopic dermatitis: A tape-strip proteomic analysis
E. Del Duca, M. Lau, Joel Corrêa da Rosa, Yeriel Estrada et autres
0 citationsJournal of Investigative Dermatology
OP0186 EFFICACY AND SAFETY OF RILZABRUTINIB, AN ORAL BRUTON'S TYROSINE KINASE INHIBITOR, IN PATIENTS WITH IgG4-RELATED DISEASE: RESULTS FROM A 52-WEEK, PHASE 2, OPEN-LABEL, PROOF-OF-CONCEPT STUDY
John H. Stone, Fernando Martínez Valle, Mollie N. Carruthers, Michael Baker et autres
7 citationsAnnals of the Rheumatic Diseases
Atuzabrutinib Topical Gel Does Not Improve Disease Activity in Patients with Mild-to-Moderate Atopic Dermatitis: Findings from a Phase 2A Trial
V. Mikol, Elham Attieh, Marie Vigan, Maria Wiekowski et autres
0 citationsJournal of Investigative Dermatology
Efficacy and safety of rilzabrutinib in patients with moderate-to-severe atopic dermatitis: 16-week results from a proof-of-concept phase II clinical trial
Leon Kircik, Athanasios Tsianakas, Fernando Valenzuela, V. Mikol et autres
8 citationsBritish Journal of Dermatology
RNA Sequencing Analysis of Nasal Brushings From Participants Administered Rilzabrutinib 1200 MG Demonstrated an Impact on Multiple Pathways Relevant for Asthma
Michael E. Wechsler, J.F. Maspero, I.D. Pavord, Cintia Palu et autres
2 citationsAmerican Journal of Respiratory and Critical Care Medicine
Rilzabrutinib in Antihistamine-Refractory Chronic Spontaneous Urticaria
Ana M. Giménez‐Arnau, Silvia Mariel Ferrucci, Moshe Ben‐Shoshan, V. Mikol et autres
31 citationsJAMA Dermatology
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium
B Rup, Marc Pallardy, Dan Sikkema, T. Albert et autres
83 citationsClinical & Experimental Immunology
The Crystal structure of Pneumococcal vaccine antigen PcpA
F. Vallee, V. Steier, E.O. Oloo, Daniel G. Chawla et autres
0 citationsWorldwide Protein Data Bank
Structural Basis for Human Monoglyceride Lipase Inhibition
Thomas Bertrand, Franck Augé, Jacques Houtmann, Alexey Rak et autres
169 citationsJournal of Molecular Biology
Crystal structure of human mono-glyceride lipase in complex with SAR629
Thomas Bertrand, Franck Augé, Alexey Rak, François Vallée et autres
0 citationsWorldwide Protein Data Bank
Crystal structure of human mono-glyceride lipase
Thomas Bertrand, Franck Augé, Jacques Houtmann, Alexey Rak et autres
1 citationWorldwide Protein Data Bank
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.